IBDEI3E5 ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,57020,1,2,0)
;;=2^DUS Art Inflow/Ven Outflow,Abdom,Limited
;;^UTILITY(U,$J,358.3,57020,1,4,0)
;;=4^93976
;;^UTILITY(U,$J,358.3,57021,0)
;;=93886^^263^2848^24^^^^1
;;^UTILITY(U,$J,358.3,57021,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57021,1,2,0)
;;=2^Intracranial Doppler,Complete
;;^UTILITY(U,$J,358.3,57021,1,4,0)
;;=4^93886
;;^UTILITY(U,$J,358.3,57022,0)
;;=93888^^263^2848^25^^^^1
;;^UTILITY(U,$J,358.3,57022,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57022,1,2,0)
;;=2^Intracranial Doppler,Limited
;;^UTILITY(U,$J,358.3,57022,1,4,0)
;;=4^93888
;;^UTILITY(U,$J,358.3,57023,0)
;;=93893^^263^2848^27^^^^1
;;^UTILITY(U,$J,358.3,57023,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57023,1,2,0)
;;=2^TCD Emboli Detect w/ Inj
;;^UTILITY(U,$J,358.3,57023,1,4,0)
;;=4^93893
;;^UTILITY(U,$J,358.3,57024,0)
;;=93892^^263^2848^28^^^^1
;;^UTILITY(U,$J,358.3,57024,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57024,1,2,0)
;;=2^TCD Emboli Detect w/o Inj
;;^UTILITY(U,$J,358.3,57024,1,4,0)
;;=4^93892
;;^UTILITY(U,$J,358.3,57025,0)
;;=76881^^263^2848^31^^^^1
;;^UTILITY(U,$J,358.3,57025,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57025,1,2,0)
;;=2^US Extrem Non Vasc,Complete
;;^UTILITY(U,$J,358.3,57025,1,4,0)
;;=4^76881
;;^UTILITY(U,$J,358.3,57026,0)
;;=76882^^263^2848^32^^^^1
;;^UTILITY(U,$J,358.3,57026,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57026,1,2,0)
;;=2^US Extrem Non Vasc,Limited
;;^UTILITY(U,$J,358.3,57026,1,4,0)
;;=4^76882
;;^UTILITY(U,$J,358.3,57027,0)
;;=E10.40^^264^2849^76
;;^UTILITY(U,$J,358.3,57027,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57027,1,3,0)
;;=3^DM Type 1 w/ DM Neuropathy,Unspec
;;^UTILITY(U,$J,358.3,57027,1,4,0)
;;=4^E10.40
;;^UTILITY(U,$J,358.3,57027,2)
;;=^5002604
;;^UTILITY(U,$J,358.3,57028,0)
;;=E10.42^^264^2849^79
;;^UTILITY(U,$J,358.3,57028,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57028,1,3,0)
;;=3^DM Type 1 w/ DM Polyneuropathy
;;^UTILITY(U,$J,358.3,57028,1,4,0)
;;=4^E10.42
;;^UTILITY(U,$J,358.3,57028,2)
;;=^5002606
;;^UTILITY(U,$J,358.3,57029,0)
;;=E10.43^^264^2849^73
;;^UTILITY(U,$J,358.3,57029,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57029,1,3,0)
;;=3^DM Type 1 w/ DM Autonomic Polyneuropathy
;;^UTILITY(U,$J,358.3,57029,1,4,0)
;;=4^E10.43
;;^UTILITY(U,$J,358.3,57029,2)
;;=^5002607
;;^UTILITY(U,$J,358.3,57030,0)
;;=E10.51^^264^2849^77
;;^UTILITY(U,$J,358.3,57030,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57030,1,3,0)
;;=3^DM Type 1 w/ DM Peripheral Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,57030,1,4,0)
;;=4^E10.51
;;^UTILITY(U,$J,358.3,57030,2)
;;=^5002610
;;^UTILITY(U,$J,358.3,57031,0)
;;=E10.52^^264^2849^78
;;^UTILITY(U,$J,358.3,57031,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57031,1,3,0)
;;=3^DM Type 1 w/ DM Peripheral Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,57031,1,4,0)
;;=4^E10.52
;;^UTILITY(U,$J,358.3,57031,2)
;;=^5002611
;;^UTILITY(U,$J,358.3,57032,0)
;;=E10.610^^264^2849^75
;;^UTILITY(U,$J,358.3,57032,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57032,1,3,0)
;;=3^DM Type 1 w/ DM Neuropathic Arthropathy
;;^UTILITY(U,$J,358.3,57032,1,4,0)
;;=4^E10.610
;;^UTILITY(U,$J,358.3,57032,2)
;;=^5002613
;;^UTILITY(U,$J,358.3,57033,0)
;;=E10.620^^264^2849^74
;;^UTILITY(U,$J,358.3,57033,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,57033,1,3,0)
;;=3^DM Type 1 w/ DM Dermatitis
;;^UTILITY(U,$J,358.3,57033,1,4,0)
;;=4^E10.620
;;^UTILITY(U,$J,358.3,57033,2)
;;=^5002615
;;^UTILITY(U,$J,358.3,57034,0)
;;=E10.621^^264^2849^80
;;^UTILITY(U,$J,358.3,57034,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3E5 3984 printed Sep 23, 2025@20:23:03 Page 2
IBDEI3E5 ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,57020,1,2,0)
+2 ;;=2^DUS Art Inflow/Ven Outflow,Abdom,Limited
+3 ;;^UTILITY(U,$J,358.3,57020,1,4,0)
+4 ;;=4^93976
+5 ;;^UTILITY(U,$J,358.3,57021,0)
+6 ;;=93886^^263^2848^24^^^^1
+7 ;;^UTILITY(U,$J,358.3,57021,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,57021,1,2,0)
+10 ;;=2^Intracranial Doppler,Complete
+11 ;;^UTILITY(U,$J,358.3,57021,1,4,0)
+12 ;;=4^93886
+13 ;;^UTILITY(U,$J,358.3,57022,0)
+14 ;;=93888^^263^2848^25^^^^1
+15 ;;^UTILITY(U,$J,358.3,57022,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,57022,1,2,0)
+18 ;;=2^Intracranial Doppler,Limited
+19 ;;^UTILITY(U,$J,358.3,57022,1,4,0)
+20 ;;=4^93888
+21 ;;^UTILITY(U,$J,358.3,57023,0)
+22 ;;=93893^^263^2848^27^^^^1
+23 ;;^UTILITY(U,$J,358.3,57023,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,57023,1,2,0)
+26 ;;=2^TCD Emboli Detect w/ Inj
+27 ;;^UTILITY(U,$J,358.3,57023,1,4,0)
+28 ;;=4^93893
+29 ;;^UTILITY(U,$J,358.3,57024,0)
+30 ;;=93892^^263^2848^28^^^^1
+31 ;;^UTILITY(U,$J,358.3,57024,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,57024,1,2,0)
+34 ;;=2^TCD Emboli Detect w/o Inj
+35 ;;^UTILITY(U,$J,358.3,57024,1,4,0)
+36 ;;=4^93892
+37 ;;^UTILITY(U,$J,358.3,57025,0)
+38 ;;=76881^^263^2848^31^^^^1
+39 ;;^UTILITY(U,$J,358.3,57025,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,57025,1,2,0)
+42 ;;=2^US Extrem Non Vasc,Complete
+43 ;;^UTILITY(U,$J,358.3,57025,1,4,0)
+44 ;;=4^76881
+45 ;;^UTILITY(U,$J,358.3,57026,0)
+46 ;;=76882^^263^2848^32^^^^1
+47 ;;^UTILITY(U,$J,358.3,57026,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,57026,1,2,0)
+50 ;;=2^US Extrem Non Vasc,Limited
+51 ;;^UTILITY(U,$J,358.3,57026,1,4,0)
+52 ;;=4^76882
+53 ;;^UTILITY(U,$J,358.3,57027,0)
+54 ;;=E10.40^^264^2849^76
+55 ;;^UTILITY(U,$J,358.3,57027,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,57027,1,3,0)
+58 ;;=3^DM Type 1 w/ DM Neuropathy,Unspec
+59 ;;^UTILITY(U,$J,358.3,57027,1,4,0)
+60 ;;=4^E10.40
+61 ;;^UTILITY(U,$J,358.3,57027,2)
+62 ;;=^5002604
+63 ;;^UTILITY(U,$J,358.3,57028,0)
+64 ;;=E10.42^^264^2849^79
+65 ;;^UTILITY(U,$J,358.3,57028,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,57028,1,3,0)
+68 ;;=3^DM Type 1 w/ DM Polyneuropathy
+69 ;;^UTILITY(U,$J,358.3,57028,1,4,0)
+70 ;;=4^E10.42
+71 ;;^UTILITY(U,$J,358.3,57028,2)
+72 ;;=^5002606
+73 ;;^UTILITY(U,$J,358.3,57029,0)
+74 ;;=E10.43^^264^2849^73
+75 ;;^UTILITY(U,$J,358.3,57029,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,57029,1,3,0)
+78 ;;=3^DM Type 1 w/ DM Autonomic Polyneuropathy
+79 ;;^UTILITY(U,$J,358.3,57029,1,4,0)
+80 ;;=4^E10.43
+81 ;;^UTILITY(U,$J,358.3,57029,2)
+82 ;;=^5002607
+83 ;;^UTILITY(U,$J,358.3,57030,0)
+84 ;;=E10.51^^264^2849^77
+85 ;;^UTILITY(U,$J,358.3,57030,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,57030,1,3,0)
+88 ;;=3^DM Type 1 w/ DM Peripheral Angiopathy w/o Gangrene
+89 ;;^UTILITY(U,$J,358.3,57030,1,4,0)
+90 ;;=4^E10.51
+91 ;;^UTILITY(U,$J,358.3,57030,2)
+92 ;;=^5002610
+93 ;;^UTILITY(U,$J,358.3,57031,0)
+94 ;;=E10.52^^264^2849^78
+95 ;;^UTILITY(U,$J,358.3,57031,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,57031,1,3,0)
+98 ;;=3^DM Type 1 w/ DM Peripheral Angiopathy w/ Gangrene
+99 ;;^UTILITY(U,$J,358.3,57031,1,4,0)
+100 ;;=4^E10.52
+101 ;;^UTILITY(U,$J,358.3,57031,2)
+102 ;;=^5002611
+103 ;;^UTILITY(U,$J,358.3,57032,0)
+104 ;;=E10.610^^264^2849^75
+105 ;;^UTILITY(U,$J,358.3,57032,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,57032,1,3,0)
+108 ;;=3^DM Type 1 w/ DM Neuropathic Arthropathy
+109 ;;^UTILITY(U,$J,358.3,57032,1,4,0)
+110 ;;=4^E10.610
+111 ;;^UTILITY(U,$J,358.3,57032,2)
+112 ;;=^5002613
+113 ;;^UTILITY(U,$J,358.3,57033,0)
+114 ;;=E10.620^^264^2849^74
+115 ;;^UTILITY(U,$J,358.3,57033,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,57033,1,3,0)
+118 ;;=3^DM Type 1 w/ DM Dermatitis
+119 ;;^UTILITY(U,$J,358.3,57033,1,4,0)
+120 ;;=4^E10.620
+121 ;;^UTILITY(U,$J,358.3,57033,2)
+122 ;;=^5002615
+123 ;;^UTILITY(U,$J,358.3,57034,0)
+124 ;;=E10.621^^264^2849^80
+125 ;;^UTILITY(U,$J,358.3,57034,1,0)
+126 ;;=^358.31IA^4^2
